People with a family history of melanoma may have a greater risk of developing Parkinson's

People with a family history of melanoma may have a greater risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009.

The study involved nearly 157,000 people who did not have Parkinson's disease. They were asked if their parents or siblings had been diagnosed with melanoma, the deadliest form of skin cancer. Researchers then traced their progress for a period of 14 to 20 years. During that time, 616 of the people were diagnosed with Parkinson's disease.

Researchers found that people with a reported family history of melanoma were nearly twice as likely to develop Parkinson's as people with no family history.

"The results from this study suggest that melanoma and Parkinson's could share common genetic components," said study author Xiang Gao, MD, PhD, of the Harvard University School of Public Health in Boston, MA. "More research needs to be done to examine the relationship between these two diseases."

Other studies have shown that people with Parkinson's disease have a greater risk of developing melanoma.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gene editing restores treatment sensitivity in melanoma